Initial high-dose therapy may help patients seeking relief
Search results for: methotrexate
Drug Updates
Information on New Approvals and Medication Safety
RA Therapy Can Increase Risk for Lung Disease
Vigilant screening for NTM lung disease and latent tuberculosis needed
Coding Corner Question
April’s Coding Challenge
Fatal Choices: Mixing Risk with Medicine
Mixing risk with medicine
The Classification Challenge of Pediatric Spondylarthritis
Condition often confused with other disorders
Drug Updates
Information on New Approvals and Medication Safety
Progress Continues in Systemic Sclerosis
Advances in genetics and potential therapies shed new light on the disease
Coding Corner Question
January’s Coding Challenge
Letters to the Editor: In Memoriam
One more prescribing rule [See “Rheuminations,” September 2009, p. 6], honored mainly in the breach, in our overspending climate: don’t prescribe an expensive brand when generics are as good or better, especially Nexium (which I have never prescribed) versus omeprazole, Lipitor versus simvastatin (which now costs the VA three cents a pill), and—for rheumatologists who are writing 80% Uloric—allopurinol except for the 10% who might need Uloric.
- « Previous Page
- 1
- …
- 94
- 95
- 96
- 97
- 98
- …
- 103
- Next Page »